10.1007/s40495-015-0041-y 13 BrayF.FerlayJ.SoerjomataramI.SiegelR
doi:10.1016/S0140-6736(23)00085-5
A landmark clinical trial published in the Journal of Clinical Endocrinology and Metabolism demonstrating that Ipamorelin produces selective GH release without significant cortisol or prolactin elevation, establishing its safety profile for use in women with hormonally sensitive physiological backgrounds is the foundational study that shaped how the peptide is used today in supervised clinical settings
Subsequently, the cells were treated with BPTES (3 M, a glutaminase inhibitor that blocks the glutamine oxidation pathway), etomoxir (4 M, a CPT1A inhibitor, which is crucial for the transport of long-chain FAs from cytosol into mitochondria for oxidation), or UK5099 (2 M, an inhibitor of the glucose oxidation pathway that blocks the mitochondrial pyruvate carrier) successively, and oxygen consumption rate (OCR) was measured prior to and after the addition of each inhibitor
Cogswell, J
Metabolic syndrome in people suffering from posttraumatic stress disorder: a systematic review and meta-analysis